ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.62
+0.08 (1.22%)
Feb 19, 2026, 12:44 PM EST - Market open
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $70.51 million as of February 19, 2026.
Market Cap
70.51M
Enterprise Value
-69.48M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.62
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $174.36M to $70.51M, a decrease of -59.56%. That is a compound annual growth rate of -80.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 69.66M | -5.22% |
| Dec 31, 2025 | 73.49M | -57.85% |
| Jul 28, 2025 | 174.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 76.69M |
| Seres Therapeutics | 76.62M |
| XBiotech | 74.69M |
| MAIA Biotechnology | 73.47M |
| MediciNova | 73.23M |
| Spruce Biosciences | 70.95M |
| Adicet Bio | 69.83M |
| Gain Therapeutics | 69.62M |